🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- G2545C104 (prev. 38000Q102 )
- Market Cap
- Micro Cap
- IPO
- 1/9/2014 · $8.00/share
- Previous Symbol
- GLYC (changed 6/23/2025)
- Previous Name
- GlycoMimetics, Inc.
Business: Crescent Biopharma, Inc. is a clinical stage oncology company bringing the next wave of therapies for cancer patients.The Company is leveraging multiple modalities and established targets, rapidly advancing potentially transformative therapies either as single agents or as part of combination regimens to treat a range of solid tumors.
Company Contact
- CEO
- Joshua Brumm
- CFO
- Rick Scalzo
- Headquarters
- 300 Fifth Avenue, Waltham, MA 02451
- Phone
- 617-430-5595
- Fax
- 301-738-2137
- Investor Relations
- Amy Reilly · 617-465-0586 · amy.reilly@crescentbiopharma.com